Flagship explainer
What drives Century Therapeutics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$9.6M | FY2025 |
| |
| Income before tax | −$9.6M | FY2025 |
|
| Operating income | −$17.3M | FY2025 |
|
| $109M | FY2025 |
| |
| Ending assets | $224M | FY2025 |
|
| Beginning assets | $353M | FY2024 |
|
| $159M | FY2025 |
| |
| $161M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001104659-26-026759